Na He

538 total citations
41 papers, 350 citations indexed

About

Na He is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Na He has authored 41 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Pharmacology. Recurrent topics in Na He's work include Liver Disease Diagnosis and Treatment (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer-related molecular mechanisms research (4 papers). Na He is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Cancer-related molecular mechanisms research (4 papers). Na He collaborates with scholars based in China, Italy and United Kingdom. Na He's co-authors include Xiaojun Ma, Wei‐Hua Yan, Gong Feng, Ming Yin, Zejian Wang, Man Mi, Zhimin Luo, Yang Yao, Rong Li and Dan Liu and has published in prestigious journals such as Advanced Drug Delivery Reviews, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Na He

40 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Na He China 11 109 100 52 45 39 41 350
Blanca Cucarull Spain 7 150 1.4× 67 0.7× 43 0.8× 49 1.1× 59 1.5× 10 330
Guangyan Yang China 14 224 2.1× 63 0.6× 37 0.7× 41 0.9× 14 0.4× 32 507
Yao Tong China 9 157 1.4× 51 0.5× 46 0.9× 57 1.3× 17 0.4× 22 396
Teresa Rubio‐Tomás Greece 12 159 1.5× 104 1.0× 33 0.6× 32 0.7× 94 2.4× 27 434
Peifeng Ke China 11 108 1.0× 56 0.6× 19 0.4× 55 1.2× 34 0.9× 54 391
Chad Pope United States 7 218 2.0× 101 1.0× 133 2.6× 85 1.9× 36 0.9× 10 491
Xiaonan Kang China 9 127 1.2× 91 0.9× 38 0.7× 24 0.5× 11 0.3× 23 375
Alexander Strigun Germany 8 196 1.8× 93 0.9× 39 0.8× 35 0.8× 20 0.5× 8 514
Zhilin Chen China 11 98 0.9× 37 0.4× 42 0.8× 64 1.4× 12 0.3× 32 319

Countries citing papers authored by Na He

Since Specialization
Citations

This map shows the geographic impact of Na He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na He more than expected).

Fields of papers citing papers by Na He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na He. The network helps show where Na He may publish in the future.

Co-authorship network of co-authors of Na He

This figure shows the co-authorship network connecting the top 25 collaborators of Na He. A scholar is included among the top collaborators of Na He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na He. Na He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Huihui, et al.. (2025). Revolutionizing Retinal Therapy: The Role of Nanoparticle Drug Carriers in Managing Vascular Retinal Disorders. Clinical ophthalmology. Volume 19. 1565–1582. 1 indexed citations
2.
He, Na, Yang Xu, Yue Kang, et al.. (2024). A high-performance electrocatalyst for sustainable ammonia synthesis via single-atom Ru-embedded Fe2O3 nitrogen-DOPED carbon. Applied Surface Science. 675. 160975–160975. 3 indexed citations
3.
Wang, Dongping, Lihong Wu, Rui Li, et al.. (2023). A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling. Marine Drugs. 21(4). 218–218. 7 indexed citations
4.
He, Na, Rui Li, Siqi Zhang, et al.. (2023). A Novel Ageladine A Derivative Acts as a STAT3 Inhibitor and Exhibits Potential Antitumor Effects. International Journal of Molecular Sciences. 24(10). 8859–8859. 1 indexed citations
5.
6.
7.
Yan, Honglin, et al.. (2022). Upregulated Circular RNA KIF4A Promotes Cell Migration and Invasion by Regulating MicroRNA-144-3p/EZH2 Axis in Gastric Cancer. Journal of Oncology. 2022. 1–10. 6 indexed citations
8.
Li, Xinhua, Lu Wang, Na He, et al.. (2022). The relationship between zinc deficiency and infectious complications in patients with hepatitis B virus-related acute-on-chronic liver failure. Gastroenterology report. 10. goac066–goac066. 2 indexed citations
9.
He, Na, et al.. (2022). The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: a meta-analysis. Annals of Hepatology. 27(4). 100705–100705. 5 indexed citations
10.
He, Na, Xuan Li, Zhimin Luo, et al.. (2022). Preparation of molecularly imprinted foam for selective extraction of toxic monocrotaline from herbs. Journal of Chromatography B. 1200. 123273–123273. 3 indexed citations
11.
Yao, Yang, et al.. (2022). Rosmarinic acid alleviates acetaminophen-induced hepatotoxicity by targeting Nrf2 and NEK7-NLRP3 signaling pathway. Ecotoxicology and Environmental Safety. 241. 113773–113773. 23 indexed citations
12.
Feng, Gong, Kenneth I. Zheng, Liang‐Jie Tang, et al.. (2022). Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?. PubMed. 1(1). 30–34. 4 indexed citations
13.
Luo, Zhimin, Xingwu Zhou, Kalpana Mandal, et al.. (2021). Reconstructing the tumor architecture into organoids. Advanced Drug Delivery Reviews. 176. 113839–113839. 31 indexed citations
14.
Zhang, Xinxin, Lei Zhang, Ming‐Ming Zhou, et al.. (2021). SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK/STAT3 signaling. Acta Biochimica et Biophysica Sinica. 53(8). 1098–1105. 8 indexed citations
15.
Feng, Gong, Man-Ling Liu, Xiaozhou Zhang, et al.. (2020). Clinical Features of COVID-19 Patients in Xiaogan City. SN Comprehensive Clinical Medicine. 2(10). 1717–1723. 2 indexed citations
16.
Yi, Hai, et al.. (2019). Risk factors for violence in schizophrenic patients at onset stage in community. Zhonghua xiandai huli zazhi. 25(16). 2029–2035. 1 indexed citations
17.
Wan, Jian, Yujie Zhang, & Na He. (2019). Intestinal microecology in inflammatory bowel disease. 3(3). 177–181. 1 indexed citations
18.
Feng, Gong, Na He, Yifan Zhou, et al.. (2018). A simpler diagnostic formula for screening nonalcoholic fatty liver disease. Clinical Biochemistry. 64. 18–23. 10 indexed citations
19.
Gao, Yongli, et al.. (2017). [Value of APACHEIIfor predicting the nursing workload in EICU].. PubMed. 29(4). 368–370.
20.
Sun, Changbin, et al.. (2016). Fundamental Principles of Stem Cell Banking. Advances in experimental medicine and biology. 951. 31–45. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Blanca Cucarull Breakdown of academic impact, for papers by Guangyan Yang Breakdown of academic impact, for papers by Yao Tong Breakdown of academic impact, for papers by Teresa Rubio‐Tomás Breakdown of academic impact, for papers by Peifeng Ke Breakdown of academic impact, for papers by Chad Pope Breakdown of academic impact, for papers by Xiaonan Kang Breakdown of academic impact, for papers by Alexander Strigun Breakdown of academic impact, for papers by Zhilin Chen
Rankless by CCL
2026